An oxygen-dependent biomimetic system for DOPA, dopamine and norepinephrine polymerization exploiting the redox properties of a 5-S-cysteinylDOPA (CD)-melanin polymer is disclosed. Kinetic, chemical and scanning electron microscopy (SEM) evidence indicates conversion of DOPA into a black insoluble polymer encapsulating the active CD-melanin core.
No takes yet. Share an insight, caveat, or question.
Greco et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: